4.7 Article

Comprehensive Search for Novel Circulating miRNAs and Axon Guidance Pathway Proteins Associated with Risk of ESKD in Diabetes

Journal

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
Volume 32, Issue 9, Pages 2331-2351

Publisher

AMER SOC NEPHROLOGY
DOI: 10.1681/ASN.2021010105

Keywords

-

Funding

  1. NIH Clinical Center grants [DK041526, DK110350, DK100449]
  2. Novo Nordisk Foundation [NNF14OC0013659]
  3. JDRF [3-SRA-2015-106-Q-R, 5-CDA-2015-89-A-B]
  4. Mary K. Iacocca Fellowship
  5. Sunstar Foundation
  6. Hiroo Kaneda Scholarship
  7. Foundation for Growth Science of Japan
  8. Uehara Memorial Foundation
  9. Japan Society for the Promotion of Science
  10. American Diabetes Association Clinical Science Award [1-08CR-42]
  11. Centers for Disease Control and Prevention Interagency [16FED1604631]
  12. National Institute of Diabetes and Digestive and Kidney Diseases Intramural Research Program
  13. NIH Clinical Center, Diabetes Endocrinology Research Center [P30 DK036836]
  14. George M. O'Brien Michigan Kidney Translational Core Center - NIH Clinical C enter/NIDDK [2P30 DK081943]

Ask authors/readers for more resources

This study investigated the mechanisms involved in the progression of diabetic kidney disease to ESKD through global miRNA analysis and proteomics analysis. Circulating miRNAs and proteins in the axon guidance pathway were found to be strongly associated with the risk of ESKD development. These findings suggest that systemic factors play an important role in the development of diabetic kidney disease and may serve as potential targets for new therapies.
Background Mechanisms underlying the pro gression of diabetic kidney disease to ESKD are not fully understood. Methods We performed global microRNA (miRNA) analysis on plasma from two cohorts consisting of 375 individuals with type 1 and type 2 diabetes with late diabetic kidney disease, and targeted proteomics analysis on plasma from four cohorts consisting of 746 individuals with late and early diabetic kidney disease. We examined structural lesions in kidney biopsy specimens from the 105 individuals with early diabetic kidney disease. Human umbilical vein endothelial cells were used to assess the effects of miRNA mimics or inhibitors on regulation of candidate proteins. Results In the late diabetic kidney disease cohorts, we identified 17 circulating miRNAs, represented by four exemplars (miR-1287-5p, miR-197-5p, miR-339-5p, and miR-328-3p), that were strongly associated with 10-year risk of ESKD. These miRNAs targeted proteins in the axon guidance pathway. Circulating levels of six of these proteins-most notably, EFNA4 and EPHA2-were strongly associated with 10-year risk of ESKD in all cohorts. Furthermore, circulating levels of these proteins correlated with severity of structural lesions in kidney biopsy specimens. In contrast, expression levels of genes encoding these proteins had no apparent effects on the lesions. In in vitro experiments, mimics of miR-1287-5p and miR-197-5p and inhibitors of miR-339-5p and miR-328-3p upregulated concentrations of EPHA2 in either cell lysate, supernatant, or both. Conclusions This study reveals novel mechanisms involved in progression to ESKD and points to the importance of systemic factors in the development of diabetic kidney disease. Some circulating miRNAs and axon guidance pathway proteins represent potential targets for new therapies to prevent and treat this condition.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available